A pilot study to evaluate the efficacy of 3 doses of L-carnitine supplementation in chronic kidney disease patients with complications caused by carnitine deficiency
Not Applicable
Recruiting
- Conditions
- chronic kidney disease
- Registration Number
- JPRN-UMIN000008585
- Lead Sponsor
- Yokohama City Minato Red Cross Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
1)history of allergy against this drug 2)ability of oral administration 3)alcoholic or drug abuse 4)cancer 5)patients who are judged to be inappropriate to this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of symptoms due to carnitine deficiency (muscle cramps, fatigue and anemia)
- Secondary Outcome Measures
Name Time Method reduction of the dose of ESA, improvement of anemia, frequency of administration of shakuyakukanzoto, change in muscle mass, improvement of cardiac function, adverse events